good efficacy among elderly patients. The safety with saxagliptin amongst elderly patients is as good as young patients; in fact hazard ratio is favorable. Saxagliptin provides significant reversal of microalbuminuria in all stages of renal failure and is effective even in normoalbuminuric diabetics, which is a big plus point when being used in elderly patients. The HOMA-B improvement and possible preservation of b cells will further improve outcome amongst elderly patients.